Showing results (51-60 of 351) with videos related to

Sort By:
Pageof 36
Intervirology|August 24, 2006
Long-term follow-up of HBeAg-positive young adult Japanese patients treated with corticosteroid withdrawal therapy for chronic hepatitis BHitomi Sezaki, Fumitaka Suzuki, Tetsuya Hosaka, et al.
Oncology|December 6, 2003
Recurrence rate and prognosis of patients with hepatocellular carcinoma that developed after elimination of hepatitis C virus RNA by interferon therapy. A closed cohort study including matched control patientsKenji Ikeda, Masahiro Kobayashi, Satoshi Saitoh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 6, 2002
Randomized, controlled trial of natural interferon-alpha therapy for e-antigen-positive chronic hepatitis B patientsYasuji Arase, Akihito Tsubota, Satoshi Saitoh, et al.
Intervirology|July 18, 2003
Histological improvements after a three-year lamivudine therapy in patients with chronic hepatitis B in whom YMDD mutants did not or did developYoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, et al.
Intervirology|March 24, 2005
Hepatitis B virus-related hepatocellular carcinogenesis and its preventionKenji Ikeda, Yasuji Arase, Masahiro Kobayashi, et al.
Intervirology|April 18, 2009
An open pilot study exploring the efficacy of fluvastatin, pegylated interferon and ribavirin in patients with hepatitis C virus genotype 1b in high viral loadsHitomi Sezaki, Fumitaka Suzuki, Norio Akuta, et al.
The American Journal of Medicine|October 31, 2006
Long-term outcome of HBV carriers with negative HBe antigen and normal aminotransferaseKenji Ikeda, Yasuji Arase, Satoshi Saitoh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 19, 2007
Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral loadHitomi Sezaki, Fumitaka Suzuki, Yusuke Kawamura, et al.
Journal of Gastroenterology|October 14, 2023
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearanceFumitaka Suzuki, Tetsuya Hosaka, Yoshiyuki Suzuki, et al.
Oncology|April 14, 2026
Serum microRNA-122 predicts early progressive disease in unresectable hepatocellular carcinoma with atezolizumab plus bevacizumab therapyShigeki Yamamoto, Norio Akuta, Tetsuya Hosaka, et al.
Pageof 36